LNAI— Lunai Bioworks Inc.

Metric	FY2025	FY2024	FY2023	FY2022
General and administrative	$17.9M-27.2%	$24.6M+60.3%	$15.3M+6.9%	$14.3M
Research and development	$537K-80.2%	$2.7M-35.0%	$4.2M-50.3%	$8.4M
Intangible asset impairment	$42.6M	—	$19.0M	—
Goodwill impairment	$170.4M+1364.1%	$11.6M	$0	—
Depreciation and amortization	$129K+5.9%	$122K+7.4%	$113K-8.2%	$124K
Total Operating Expenses	$189.0M+131.5%	$81.6M+111.7%	$38.6M-66.8%	$116.1M
LOSS FROM OPERATIONS	-$189.0M-131.5%	-$81.6M-111.7%	-$38.6M+66.8%	-$116.1M
Change in fair value of contingent consideration	$11.7M+483.2%	-$3.0M	$0	—
Loss on extinguishment of debt	$0+100.0%	-$1.3M	$0	—
Change in fair value of equity securities	-$112K	—	—	—
Interest expense	-$726K+28.2%	-$1.0M-74.3%	-$580K-55.7%	-$373K
Interest income and other income (expense)	$116K+108.2%	-$1.4M-1024.2%	-$127K-203.8%	$122K
Total Other Income (Expense)	$11.0M+261.5%	-$6.8M-502.1%	-$1.1M-142.6%	$2.6M
NET LOSS	-$178.0M-101.3%	-$88.4M-122.8%	-$39.7M+65.0%	-$113.4M
BASIC NET LOSS PER COMMON SHARE	-$1.08-18.7%	-$0.91-28.2%	-$0.71	—
DILUTED NET LOSS PER COMMON SHARE	-$1.08-18.7%	-$0.91-28.2%	-$0.71	—
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING - BASIC	165.1M+69.3%	97.5M+73.3%	56.3M	—
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING - DILUTED	165.1M+69.3%	97.5M+73.3%	56.3M	—

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.